Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prenate Elite is a prenatal multivitamin and multimineral dietary supplement manufactured by Avion Pharmaceuticals. It is specifically indicated for improving the nutritional status of women throughout pregnancy and in the postnatal period, supporting both lactating and non-lactating mothers. The formulation includes a comprehensive array of essential nutrients, notably a combination of folic acid and L-methylfolate (as 5-methyltetrahydrofolic acid), which are critical for preventing neural tube defects and supporting fetal development. Other key components include iron (as ferrous asparto glycinate), iodine, magnesium, zinc, and a full spectrum of vitamins (A, C, D, E, and B-complex). As a nutritional supplement, it functions by replenishing and maintaining optimal levels of vitamins and minerals required for maternal health and proper embryonic and fetal growth, rather than targeting specific disease-related receptors in a traditional pharmaceutical manner.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prenate Elite.